- Home
- KYMR vs CNO Comparison
KYMR vs CNO Comparison
Compare KYMR & CNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- CNO
- Stock Information
- Founded
- KYMR 2015
- CNO 1979
- Country
- KYMR United States
- CNO United States
- Employees
- KYMR N/A
- CNO N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- CNO Accident &Health Insurance
- Sector
- KYMR Health Care
- CNO Finance
- Exchange
- KYMR Nasdaq
- CNO Nasdaq
- Market Cap
- KYMR 4.7B
- CNO 3.8B
- IPO Year
- KYMR 2020
- CNO 1987
- Fundamental
- Price
- KYMR $67.94
- CNO $41.47
- Analyst Decision
- KYMR Strong Buy
- CNO Hold
- Analyst Count
- KYMR 19
- CNO 5
- Target Price
- KYMR $68.95
- CNO $43.60
- AVG Volume (30 Days)
- KYMR 696.1K
- CNO 619.7K
- Earning Date
- KYMR 11-04-2025
- CNO 11-03-2025
- Dividend Yield
- KYMR N/A
- CNO 1.63%
- EPS Growth
- KYMR N/A
- CNO 20.08
- EPS
- KYMR N/A
- CNO 2.98
- Revenue
- KYMR $43,735,000.00
- CNO $4,441,500,000.00
- Revenue This Year
- KYMR $60.88
- CNO N/A
- Revenue Next Year
- KYMR N/A
- CNO $3.27
- P/E Ratio
- KYMR N/A
- CNO $14.01
- Revenue Growth
- KYMR N/A
- CNO N/A
- 52 Week Low
- KYMR $19.45
- CNO $34.63
- 52 Week High
- KYMR $68.80
- CNO $43.20
- Technical
- Relative Strength Index (RSI)
- KYMR 68.81
- CNO 59.13
- Support Level
- KYMR $63.86
- CNO $39.41
- Resistance Level
- KYMR $68.80
- CNO $41.96
- Average True Range (ATR)
- KYMR 3.52
- CNO 0.86
- MACD
- KYMR 0.19
- CNO 0.03
- Stochastic Oscillator
- KYMR 94.07
- CNO 80.55
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.